Literature DB >> 22253454

Heart failure and socioeconomic status: accumulating evidence of inequality.

Nathaniel M Hawkins1, Pardeep S Jhund, John J V McMurray, Simon Capewell.   

Abstract

AIMS: Socioeconomic status (SES) is a powerful predictor of incident coronary disease and adverse cardiovascular outcomes. Understanding the impact of SES on heart failure (HF) development and subsequent outcomes may help to develop effective and equitable prevention, detection, and treatment strategies METHODS AND
RESULTS: A systematic literature review of electronic databases including PubMed, EMBASE, CINAHL, and the Cochrane Library, restricted to human subjects, was carried out. The principal outcomes were incidence, prevalence, hospitalizations, mortality, and treatment of HF. Socioeconomic measures included education, occupation, employment relations, social class, income, housing characteristics, and composite and area level indicators. Additional studies were identified from bibliographies of relevant articles and reviews. Twenty-eight studies were identified. Lower SES was associated with increased incidence of HF, either in the community or presenting to hospital. The adjusted risk of developing HF was increased by ∼30-50% in most reports. Readmission rates following hospitalization were likewise greater in more deprived patients. Although fewer studies examined mortality, lower SES was associated with poorer survival. Evidence defining the equity of medical treatment of patients with HF was scarce and conflicting.
CONCLUSIONS: Socioeconomic deprivation is a powerful independent predictor of HF development and adverse outcomes. However, the precise mechanisms accounting for this risk remain elusive. Heart failure represents the endpoint of numerous different pathophysiological processes and 'chains of events', each modifiable throughout the disease trajectories. The interaction between SES and HF is accordingly complex. Disentangling the many and varied life course processes is challenging. A better understanding of these issues may help attenuate the health inequalities so clearly evident among patients with HF.

Entities:  

Mesh:

Year:  2012        PMID: 22253454     DOI: 10.1093/eurjhf/hfr168

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  90 in total

1.  The Association of Socioeconomic Status With Subclinical Myocardial Damage, Incident Cardiovascular Events, and Mortality in the ARIC Study.

Authors:  Anna Fretz; Andrea L C Schneider; John W McEvoy; Ron Hoogeveen; Christie M Ballantyne; Josef Coresh; Elizabeth Selvin
Journal:  Am J Epidemiol       Date:  2016-02-08       Impact factor: 4.897

2.  Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry.

Authors:  Yevgeniy Khariton; Adrian F Hernandez; Gregg C Fonarow; Puza P Sharma; Carol I Duffy; Laine Thomas; Xiaojuan Mi; Nancy M Albert; Javed Butler; Kevin McCague; Michael E Nassif; Fredonia B Williams; Adam DeVore; J Herbert Patterson; John A Spertus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-04

3.  Interleukin-1 Blockade in Acute Decompensated Heart Failure: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study.

Authors:  Benjamin W Van Tassell; Nayef A Abouzaki; Claudia Oddi Erdle; Salvatore Carbone; Cory R Trankle; Ryan D Melchior; Jeremy S Turlington; Clinton J Thurber; Sanah Christopher; Dave L Dixon; Daniel T Fronk; Christopher S Thomas; Scott W Rose; Leo F Buckley; Charles A Dinarello; Giuseppe Biondi-Zoccai; Antonio Abbate
Journal:  J Cardiovasc Pharmacol       Date:  2016-06       Impact factor: 3.105

4.  Socioeconomic Position and Incidence of Glomerular Diseases.

Authors:  Mark Canney; Dilshani Induruwage; Anahat Sahota; Cathal McCrory; Michelle A Hladunewich; Jagbir Gill; Sean J Barbour
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-20       Impact factor: 8.237

5.  Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care.

Authors:  Bosco Baron-Franco; Gary McLean; Frances S Mair; Veronique L Roger; Bruce Guthrie; Stewart W Mercer
Journal:  Br J Gen Pract       Date:  2017-04-10       Impact factor: 5.386

6.  Lower educational level and unemployment increase the impact of cardiometabolic conditions on the quality of life: results of a population-based study in South Australia.

Authors:  David Alejandro González-Chica; Robert Adams; Eleonora Dal Grande; Jodie Avery; Phillipa Hay; Nigel Stocks
Journal:  Qual Life Res       Date:  2017-02-11       Impact factor: 4.147

7.  How Health Humanities Will Save the Life of the Humanities.

Authors:  Craig M Klugman
Journal:  J Med Humanit       Date:  2017-12

8.  Design and Rationale of a Randomized Trial of a Care Transition Strategy in Patients With Acute Heart Failure Discharged From the Emergency Department: GUIDED-HF (Get With the Guidelines in Emergency Department Patients With Heart Failure).

Authors:  Gregory J Fermann; Phillip D Levy; Peter Pang; Javed Butler; S Imran Ayaz; Douglas Char; Patrick Dunn; Cathy A Jenkins; Christy Kampe; Yosef Khan; Vijaya A Kumar; JoAnn Lindenfeld; Dandan Liu; Karen Miller; W Frank Peacock; Samaa Rizk; Chad Robichaux; Russell L Rothman; Jon Schrock; Adam Singer; Sarah A Sterling; Alan B Storrow; Cheryl Walsh; John Wilburn; Sean P Collins
Journal:  Circ Heart Fail       Date:  2017-02       Impact factor: 8.790

9.  Impact of Ethnicity, Sex, and Socio-Economic Status on the Risk for Heart Failure Readmission: The Importance of Context.

Authors:  Sonia G Ponce; Jeffrey Norris; Diane Dodendorf; Melissa Martinez; Bart Cox; Warren Laskey
Journal:  Ethn Dis       Date:  2018-04-26       Impact factor: 1.847

10.  Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing).

Authors:  Kevin J Clerkin; Arthur Reshad Garan; Brian Wayda; Raymond C Givens; Melana Yuzefpolskaya; Shunichi Nakagawa; Koji Takeda; Hiroo Takayama; Yoshifumi Naka; Donna M Mancini; Paolo C Colombo; Veli K Topkara
Journal:  Circ Heart Fail       Date:  2016-10       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.